Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients

Sridurga Mithraprabhu; John Reynolds; Hang Quach; Noemi Horvath; Ian Kerridge; Tiffany Khong; Brian G.M. Durie; Andrew Spencer

doi:10.3324/haematol.2023.283831

Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients

Sridurga Mithraprabhu, John Reynolds, Hang Quach, Noemi Horvath, Ian Kerridge, Tiffany Khong, Brian G.M. Durie, Andrew Spencer

Australian Centre for Blood Diseases

Research output: Contribution to journal › Letter › Research › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	974-978
Number of pages	5
Journal	Haematologica
Volume	109
Issue number	3
DOIs	https://doi.org/10.3324/haematol.2023.283831
Publication status	Published - Mar 2024

Access to Document

10.3324/haematol.2023.283831Licence: CC BY-NC

Cite this

@article{0a30620328cc400ab108cb3e6779a12e,

title = "Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients",

author = "Sridurga Mithraprabhu and John Reynolds and Hang Quach and Noemi Horvath and Ian Kerridge and Tiffany Khong and Durie, {Brian G.M.} and Andrew Spencer",

note = "Funding Information: The authors would like to acknowledge the contribution of the staff and patients at the Malignant Hematology and Stem Cell Transplantation, Alfred Hospital, the staff at the Department of Pathology, Alfred Hospital and the Australasian Leukemia and Lymphoma Group (ALLG) network. This study was funded by the International Myeloma Foundation{\textquoteright}s Black Swan Research Initiative and philanthropic funding through the Alfred Foundation. Funding Information: This study was funded by the International Myeloma Foundation{\textquoteright}s Black Swan Research Initiative and philanthropic funding through the Alfred Foundation.",

year = "2024",

month = mar,

doi = "10.3324/haematol.2023.283831",

language = "English",

volume = "109",

pages = "974--978",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Fondazione Ferrata Storti",

number = "3",

}

TY - JOUR

T1 - Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients

AU - Mithraprabhu, Sridurga

AU - Reynolds, John

AU - Quach, Hang

AU - Horvath, Noemi

AU - Kerridge, Ian

AU - Khong, Tiffany

AU - Durie, Brian G.M.

AU - Spencer, Andrew

N1 - Funding Information: The authors would like to acknowledge the contribution of the staff and patients at the Malignant Hematology and Stem Cell Transplantation, Alfred Hospital, the staff at the Department of Pathology, Alfred Hospital and the Australasian Leukemia and Lymphoma Group (ALLG) network. This study was funded by the International Myeloma Foundation’s Black Swan Research Initiative and philanthropic funding through the Alfred Foundation. Funding Information: This study was funded by the International Myeloma Foundation’s Black Swan Research Initiative and philanthropic funding through the Alfred Foundation.

PY - 2024/3

Y1 - 2024/3

UR - http://www.scopus.com/inward/record.url?scp=85186747635&partnerID=8YFLogxK

U2 - 10.3324/haematol.2023.283831

DO - 10.3324/haematol.2023.283831

M3 - Letter

C2 - 37767561

AN - SCOPUS:85186747635

SN - 0390-6078

VL - 109

SP - 974

EP - 978

JO - Haematologica

JF - Haematologica

IS - 3

ER -

Circulating tumor DNA and bone marrow minimal residual disease negativity confers superior outcome for multiple myeloma patients

Access to Document

Other files and links

Cite this